NIH-funded research Fellowship grant

Investigating genetic factors linked to male-biased autism

Official title: Defining critical MECP2 cis-regulatory elements towards identifying genetic candidates for male-biased autism

Funded at Baylor College of Medicine · NIH-10996466 · Data updated 2026-11-12

This study is looking at how certain changes in a gene called MECP2 might play a role in autism, especially in boys, by exploring how these changes affect brain development and behavior, using cutting-edge tools to better understand the biology behind autism and find new genetic clues for future research.

More Autism research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$74,284
NIH project number1F32HD116501-01
Project IDNIH-10996466 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are young males aged 0-11 years who are diagnosed with autism spectrum disorder (ASD).

Less likely to help

Patients who are female or older than 11 years may not receive direct benefits from this research.

What this research studies

This research focuses on understanding how specific genetic elements related to the MECP2 gene may contribute to autism, particularly in males. By examining non-coding mutations in the MECP2 gene's regulatory regions, the study aims to identify how these mutations affect brain development and behavior. Researchers will use advanced techniques, including CRISPR, to manipulate these genetic elements in human neurons and assess their impact on MECP2 expression and related molecular characteristics. This could provide insights into the biological mechanisms underlying autism and help identify potential genetic candidates for further study.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential interventions for autism in males.

How similar studies have gone: Previous research has shown promising results in understanding the role of MECP2 in neurodevelopmental disorders, indicating that this approach has potential for success.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Schuman, Rebecca Meyer — Baylor College of Medicine
  • Study coordinator: Schuman, Rebecca Meyer

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.